P029 – Prioritising Precision Medicine in Asia

Organized Session 8

Date: Wednesday 8 May 2024
Time: 14:30 - 15:45 PM
Room: Ballroom C
Speakers: Hwee Lin Wee, Yot Teerawattananon, Asrul Akmal Shafie, Jeonghoon Ahn, Yue Xiao

Details descriptions of the session:

This interactive panel discussion is designed to critically analyze and discuss the implications, progress, and future prospects for the prioritization of personalised and precision medicine in the Asian healthcare sector. The session leans on a report published by the ISPOR Personalised and Precision Medicine Special Interest group (Faulkner et al 2020; henceforth ISPOR P&PM). Our aim is to validate and translate the findings and strategies of the ISPOR report to diverse Asian medical economic and socio-cultural contexts.

Learning objectives:
  • To understand the applicability and limitations of concepts from ISPOR P&PM within Asian healthcare systems.
  • To compare advancements in precision medicine across different Asian countries.
  • To engage in a critical analysis of the discrepancies, if any, between Western experience and Asian experiences in prioritising precision medicine.
Target Audience:
  • Healthcare professionals and policymakers involved in Health Technology Assessment (HTA) and precision medicine.
  • Researchers and academicians interested in the globalization of healthcare practices, particularly in personalized medicine.
  • Medical practitioners looking to understand broader applications and considerations in the field of precision medicine.
Structure of presentation:

The 75-minute session will be segmented as follows:

  • Introduction of the Session Context (5 mins):
    Brief outlining of the session’s aims, the importance of the topic under consideration, and introduction of the panelists.
  • Presentation of the Original Report (15 mins):
    Prof Wee Hwee Lin, from the ISPOR Special Interest group, will distil the essential aspects of the original paper, focusing on the themes relevant to Asian healthcare contexts.
  • Responses from Asian HTA Experts (40 mins):
    Four experts from Thailand, Malaysia, South Korea, and China (Teerawattananon, Shafie, Ahn and Xiao) will provide 10-minute insights into the state of precision medicine in their respective countries, responding to the themes raised by Hwee Lin.
  • Audience Interactive Segment (10 mins):
    Using polling software, we will gather real-time, structured feedback and queries from the audience, ensuring wide-ranging participation and engagement.
  • Panel Response and Wrap-up Discussion (5 mins):
    Panelists briefly address the audience’s input and conclude the session by summarizing the key takeaways, emphasizing collaborative progress and future exploration in the field.

Note: There will be no breakout sessions due to time constraints; however, the structured interactive segment is designed to maximize audience participation.

  • Hwee Lin Wee – National University of Singapore
  • Yot Teerawattananon – HITAP
  • Asrul Akmal Shafie – Universiti Sains Malaysia
  • Jeonghoon Ahn – Ewha Womens University
  • Yue Xiao – China National Health Development Research Centre
Scroll to Top